Bupropion metabolites and methods of their synthesis and use

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/137 (2006.01) A61P 25/00 (2006.01)

Patent

CA 2400482

Methods and compositions are disclosed which utilize metabolites of bupropion for treating disorders ameliorated by inhibition of neuronal monoamine reuptake. Such disorders include, but are not limited to, sexual dysfunction, affective disorders, cerebral function disorders, cigarette smoking, and incontinence. Methods of making optically pure bupropion metabolites are also disclosed.

L'invention concerne des procédés et des compositions qui utilisent des métabolites du bupropion pour traiter des troubles que l'on atténue par l'inhibition de la réabsorption neuronale des monoamines. De tels troubles sont notamment : les dysfonctionnement sexuels, les troubles affectifs, les troubles des fonctions cérébrales, l'usage du tabac et l'incontinence. L'invention concerne également des procédés de fabrication de métabolites du bupropion optiquement purs.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Bupropion metabolites and methods of their synthesis and use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bupropion metabolites and methods of their synthesis and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bupropion metabolites and methods of their synthesis and use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1838175

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.